Suppr超能文献

反复使用单胺转运体抑制剂抗抑郁药对大鼠颅内自我刺激相关疼痛抑郁的影响。

Effects of repeated treatment with monoamine-transporter-inhibitor antidepressants on pain-related depression of intracranial self-stimulation in rats.

机构信息

Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, 23298, USA.

出版信息

Psychopharmacology (Berl). 2020 Jul;237(7):2201-2212. doi: 10.1007/s00213-020-05530-y. Epub 2020 May 8.

Abstract

RATIONALE

Synaptic neurotransmission with dopamine (DA), norepinephrine (NE), and serotonin (5-HT) is terminated primarily by reuptake into presynaptic terminals via the DA, NE, and 5-HT transporters (DAT/NET/SERT, respectively). Monoamine transporter inhibitors constitute one class of drugs used to treat both depression and pain, and therapeutic effects by these compounds often require repeated treatment for days or weeks.

OBJECTIVES

The present study compared antinociceptive effects produced by repeated treatment with monoamine transporter inhibitors in a preclinical assay of pain-related depression of positively reinforced operant responding.

METHODS

Adult Sprague-Dawley rats equipped with microelectrodes targeting a brain-reward area responded for pulses of electrical brain stimulation in an intracranial self-stimulation (ICSS) procedure. Intraperitoneal injection of dilute lactic acid served as a noxious stimulus that repeatedly depressed ICSS and also produced weight loss during 7 days of repeated acid administration.

RESULTS

Acid-induced depression of both ICSS and body weight were completely blocked by repeated pretreatment with the nonsteroidal anti-inflammatory drug ketorolac. The DAT-selective inhibitor bupropion also fully blocked acid-induced ICSS depression and weight loss throughout all 7 days of treatment. The NET-selective inhibitor nortriptyline and the SERT-selective inhibitor citalopram were generally less effective, but both drugs blocked acid-induced ICSS depression by the end of the 7-day treatment. Acid-induced depression of ICSS and body weight were not blocked by the kappa opioid receptor (KOR) agonist U69593 or the KOR antagonist norbinaltorphimine.

CONCLUSIONS

These results support effectiveness of bupropion to alleviate signs of pain-related behavioral depression in rats and further suggest that nortriptyline and citalopram produce significant but less reliable effects.

摘要

原理

多巴胺(DA)、去甲肾上腺素(NE)和 5-羟色胺(5-HT)的突触神经传递主要通过 DA、NE 和 5-HT 转运体(分别为 DAT/NET/SERT)重新摄取到突触前末端而终止。单胺转运体抑制剂构成了一类用于治疗抑郁症和疼痛的药物,这些化合物的治疗效果通常需要重复治疗数天或数周。

目的

本研究比较了单胺转运体抑制剂在与疼痛相关的正强化操作性反应抑郁的临床前疼痛模型中重复治疗产生的镇痛作用。

方法

成年 Sprague-Dawley 大鼠配备了针对大脑奖励区域的微电极,以在颅内自我刺激(ICSS)程序中响应电脑刺激脉冲。腹腔注射稀乳酸作为有害刺激,可反复抑制 ICSS,并在重复酸给药的 7 天内导致体重减轻。

结果

非甾体抗炎药酮咯酸的重复预处理完全阻断了酸诱导的 ICSS 和体重下降。DAT 选择性抑制剂安非他酮也完全阻断了酸诱导的 ICSS 抑制和体重减轻,整个 7 天的治疗期间均如此。NET 选择性抑制剂去甲替林和 SERT 选择性抑制剂西酞普兰的效果通常较差,但这两种药物在 7 天治疗结束时均阻断了酸诱导的 ICSS 抑制。κ 阿片受体(KOR)激动剂 U69593 或 KOR 拮抗剂 norbinaltorphimine 均未阻断酸诱导的 ICSS 抑制和体重减轻。

结论

这些结果支持安非他酮缓解大鼠与疼痛相关的行为性抑郁迹象的有效性,并进一步表明去甲替林和西酞普兰产生了显著但不太可靠的效果。

相似文献

1
Effects of repeated treatment with monoamine-transporter-inhibitor antidepressants on pain-related depression of intracranial self-stimulation in rats.
Psychopharmacology (Berl). 2020 Jul;237(7):2201-2212. doi: 10.1007/s00213-020-05530-y. Epub 2020 May 8.
2
Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats.
J Pain. 2013 Mar;14(3):246-59. doi: 10.1016/j.jpain.2012.11.006. Epub 2013 Jan 16.
4
Effects of repeated treatment with methcathinone, mephedrone, and fenfluramine on intracranial self-stimulation in rats.
Psychopharmacology (Berl). 2019 Mar;236(3):1057-1066. doi: 10.1007/s00213-018-5029-y. Epub 2018 Sep 19.
5
Relief of Pain-Depressed Behavior in Rats by Activation of D1-Like Dopamine Receptors.
J Pharmacol Exp Ther. 2017 Jul;362(1):14-23. doi: 10.1124/jpet.117.240796. Epub 2017 Apr 14.
6
Effects of monoamine uptake inhibitors on pain-related depression of nesting in mice.
Behav Pharmacol. 2019 Sep;30(6):463-470. doi: 10.1097/FBP.0000000000000469.
7
8
Effects of the δ opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats.
J Pain. 2012 Apr;13(4):317-27. doi: 10.1016/j.jpain.2011.12.003. Epub 2012 Mar 15.
9
Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats.
Psychopharmacology (Berl). 2010 Jun;210(2):149-59. doi: 10.1007/s00213-009-1770-6. Epub 2010 Jan 26.
10
Role of 5-HT₂C receptors in effects of monoamine releasers on intracranial self-stimulation in rats.
Psychopharmacology (Berl). 2015 Sep;232(17):3249-58. doi: 10.1007/s00213-015-3982-2. Epub 2015 Jun 5.

引用本文的文献

1
Effects of (2R,6R)-hydroxynorketamine in assays of acute pain-stimulated and pain-depressed behaviors in mice.
PLoS One. 2024 Apr 19;19(4):e0301848. doi: 10.1371/journal.pone.0301848. eCollection 2024.
4
Does urinary metabolite signature act as a biomarker of post-stroke depression?
Front Psychiatry. 2022 Aug 24;13:928076. doi: 10.3389/fpsyt.2022.928076. eCollection 2022.
5
Acute pain-related depression of operant responding maintained by social interaction or food in male and female rats.
Psychopharmacology (Berl). 2022 Feb;239(2):561-572. doi: 10.1007/s00213-021-06048-7. Epub 2022 Jan 19.
6
The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats.
Psychopharmacology (Berl). 2021 Dec;238(12):3463-3476. doi: 10.1007/s00213-021-05965-x. Epub 2021 Aug 25.
7
Lack of effect of different pain-related manipulations on opioid self-administration, reinstatement of opioid seeking, and opioid choice in rats.
Psychopharmacology (Berl). 2021 Jul;238(7):1885-1897. doi: 10.1007/s00213-021-05816-9. Epub 2021 Mar 25.
9
Attenuated dopamine receptor signaling in nucleus accumbens core in a rat model of chemically-induced neuropathy.
Neuropharmacology. 2020 Apr;166:107935. doi: 10.1016/j.neuropharm.2020.107935. Epub 2020 Jan 7.

本文引用的文献

1
Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders.
Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:615-636. doi: 10.1146/annurev-pharmtox-010919-023317.
3
Experimental design and analysis for consideration of sex as a biological variable.
Neuropsychopharmacology. 2019 Dec;44(13):2159-2162. doi: 10.1038/s41386-019-0458-9. Epub 2019 Jul 5.
4
Core Outcome Measures in Preclinical Assessment of Candidate Analgesics.
Pharmacol Rev. 2019 Apr;71(2):225-266. doi: 10.1124/pr.118.017210.
5
Pros and Cons of Clinically Relevant Methods to Assess Pain in Rodents.
Neurosci Biobehav Rev. 2019 May;100:335-343. doi: 10.1016/j.neubiorev.2019.03.009. Epub 2019 Mar 15.
6
Pain-Induced Negative Affect Is Mediated via Recruitment of The Nucleus Accumbens Kappa Opioid System.
Neuron. 2019 May 8;102(3):564-573.e6. doi: 10.1016/j.neuron.2019.02.029. Epub 2019 Mar 13.
7
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain.
J Neurosci. 2019 May 22;39(21):4162-4178. doi: 10.1523/JNEUROSCI.0274-19.2019. Epub 2019 Mar 12.
9
Pharmacological treatments of neuropathic pain: The latest recommendations.
Rev Neurol (Paris). 2019 Jan-Feb;175(1-2):46-50. doi: 10.1016/j.neurol.2018.08.005. Epub 2018 Oct 11.
10
Severe bupropion XR abuse in a patient with long-standing bulimia nervosa and complex PTSD.
Int J Eat Disord. 2018 Oct;51(10):1207-1209. doi: 10.1002/eat.22948. Epub 2018 Sep 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验